Clinical Trial Update: Camrelizumab Combined With CRT for Treatment of Patients With Local Recurrence of Esophageal Cancer [Phase 2]

View source ↗

Summary

Phase 2 trial exploring camrelizumab with chemoradiotherapy for local recurrence of esophageal cancer.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Esophageal Cancer

Drugs mentioned

• Camrelizumab (camrelizumab)

Snippet

Sponsor: The First Affiliated Hospital of Henan University of Science and Technology | Conditions: Esophageal Cancer | Phase 2 | Status: UNKNOWN